coverag initi august
divis
rais estim ep
sept adjust ep jump cent vs cent year earlier cent
estim due higher anticip sale margin aid major restructur
factor out-performance continu progress restructur
ep project
ep estim project exceed
lead world-wide dental product manufactur report sept adjust ep
cent vs cent last year compar report year-over-year period yoy unless otherwis indic
cent estim exclud preciou metal pm content million normal
impact commod gold/silv price show sale exclud pm earn model separ line
item sale rose yoy million organ basi
 equip sale rose organ continu momentum
primescan see lack distributor inventori destock year ago reduc sale
million equip instrument sale declin oper margin jump bp sale
due higher sale oper effici consum rose organ rebound
yoy declin last quarter due time order growth restor endodont product
offset declin lab consum oper margin rose bp price cost save
organ basi revenu rose emea primescan lack
disrupt consum last year rest world row
gross margin ex-pm sale bp due cost reduct price sg expens
decreas million due save restructur reduc headcount divestitur
under-perform busi improv revenu vs adjust oper profit rose
million improv ex-pm sale vs net interest expens
million vs million tax rate vs adjust net incom jump million
ex-pm net profit margin sale vs
pleas see import disclosur end report
balanc sheet septemb show cash equival million total debt
billion debt-to-tot capit ratio vs year earlier high
septemb acquisit astratech
flow oper cfo million vs million year earlier total
million year-to-d vs million free cash flow priorit order import
reinvest busi accret stock buyback dividend increas million
share repurchas quarter million per share averag approxim million
remain board author
sale earn outlook
dentspli continu realiz benefit major restructur plan headcount reduct target
exceed suppli chain procur function central four under-perform busi divest
new salesforc effect program common system launch six month ago
good result roll intern next quarter restructur plan expect
gener million annual cost save includ million
oper margin end increas end
restructur plan also involv put focu larger opportun move
small project larg idea dentspli see better-than-anticip result recent launch
primescan start full softwar suit chairsid restor
compani believ accur digit scanner avail offer speed scan full jaw
second eas use demand primescan continu outstrip suppli although dentspli realiz
higher-than-anticip primescan product dentspli expect fulli meet demand
octob ds world event dentspli introduc one ds program offer dentist discount
rebat equip consum base purchas custom dentspli equip
purchas consum year-end earn rebat dentist sign-up
greater-than-anticip expect ds program help consum growth current quarter given
slightli higher percentag discount later year purchas consum
earn rebat compani lose share implant work improv result
new leadership team brand consolid well new product astratech implant
ev consum also help new product restor endodont allow
time save better clinic outcom sale remain strong continu primescan momentum
dec ep estim cent vs cent year earlier previou estim
cent top line million ex-pm vs billion
ep estim rais vs record adjust compani
rais guidanc previou revenu billion vs
billion compani guidanc still billion compani guidanc
includ futur share repurchas intern growth target upper end help
lack distributor destock last year neg impact sale million
model gross margin oper margin compani guidanc still
capit spend estim million exclud amort purchas
intang million dividend million result gross/fre cash flow
per share respect sap system alreadi implement roll intern
next year
ep estim project assum progress
initi detail revenu year model billion forecast oper
margin ex-pm revenu vs project net margin project bp
pleas see import disclosur end report
divis wellington shield co llc
ex-pm revenu long-term target includ revenu growth consum grow
 return growth growth thereaft double-digit ep growth
share sell forward ep estim around project
year ep growth rate depress level rate gradual accumul
continu recoveri price target share would trade
much ep estim share trade trail price-to-report earn ratio
current sell estim ebitda million estim
ebitda billion
realiz expect revenue/cost synergi major restructur plan new ceo
primari risk compani report investig sec divis enforc regard
account disclosur pwc compani auditor sign financi statement without
request extens scrutin report impact econom condit includ job loss
procedur deferr trade-down result risk sale outsid
 compani expos fx fluctuat gener reimburs concern impact
result signific impact outsid particularli germani limit
reimburs domest anoth consider regulatori environ includ fda regul
introduct manufactur advertis label packag market distribut product
pleas see import disclosur end report
divis wellington shield co llc
dec year-end
million except per share data
good sold
good sold
compani report great lake review estim cleveland oh elliott schlang jason rodger
pleas see import disclosur end report
